The Effect of Serum 25-Hydroxyvitamin D on Serum Ferritin Concentrations: A Longitudinal Study of Participants of a Preventive Health Program

• Main Authors: Lalani L. Munasinghe, John P. Ekwaru, Silmara S. B. S. Mastroeni, Marco F. Mastroeni, Paul J. Veugelers
• Format: Article
• Language: English
• Published: MDPI AG 2019-03-01
• Series: Nutrients
• Subjects: serum ferritin; vitamin D; inflammation; body weight status; cardiovascular disease; Canadians
• Online Access: https://www.mdpi.com/2072-6643/11/3/692

Various studies have suggested a role of vitamin D in inflammation. However, its effect on ferritin, a biomarker of inflammation, has received relatively little attention. Therefore, we aimed to assess the association of serum 25-hydroxyvitamin D (25(OH)D) with serum ferritin (SF) concentrations, and to examine whether temporal increases in serum 25(OH)D concentrations are paralleled by a reduction in SF concentrations. Data from a community sample of Canadian adults who participated in a preventive health program (<i>n</i> = 6812) were analyzed. During the follow-up, serum 25(OH)D concentrations increased from 80.7 to 115.0 nmol/L whereas SF concentrations decreased from 122.0 to 92.0 &#181;g/L (median follow-up time was 11.67 months). Cross-sectional analyses revealed that compared to participants with 25(OH)D concentrations of &lt;50 nmol/L, those with 25(OH)D concentrations of 75 to &lt;100, 100 to &lt;125, and &#8805;125 nmol/L had SF concentrations that were 13.00, 23.15, and 27.59 &#181;g/L lower respectively (<i>p</i> &lt; 0.001). Compared to those without temporal improvements in 25(OH)D concentrations between baseline and follow-up, participants who improved their 25(OH)D concentrations with &#8805;50 nmol/L decreased their SF concentrations with 5.71 &#181;g/L. For participants for whom the increase in 25(OH)D concentrations was less than 50 nmol/L, decreases in SF concentrations were less pronounced and not statistically significant. These observations suggest that despite strong associations between 25(OH)D and SF concentrations, interventions aiming to lower SF concentrations through sun-exposure and vitamin D supplementation should target substantial increases in 25(OH)D concentrations.